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Introduction Underlying Pathophysiology
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Human papillomavirus (HPV) and 
cervical cancer are related issues that 
are important topics to discuss.  
According to the American Cancer 
Society (ACS) (2018) it is estimated 
that in 2018 “about 13,240 new cases 
of invasive cervical cancer will be 
diagnosed.” 
The National Cervical Cancer 
Coalition (NCCC) reports that cervical 
cancer “can almost always be prevented 
through regular screening and, if 
needed, treatment of abnormal cell 
changes” (2018). Human 
papillomavirus (HPV) is the virus that 
is linked to “abnormal cell changes on 
the cervix” (NCCC, 2018).  
Why is this topic 
important?  
• Future interest in women’s health 
practice or public health would 
address the topic of cervical 
cancer and HPV.  
• Nurse practitioners and other 
healthcare providers need to be 
aware of the up to date 
information to accurately screen 
and treat patients. 
“Cervical cancer was one of the first 
human cancers to illustrate the now 
generally accepted concept that there is a 
step-wise progression from normal cells, 
to dysplastic cells, and finally to invasive 
disease. Cervical intraepithelial neoplasia 
(CIN) refers to pre-invasive dysplasia of 
cervical epithelial cells. It is the antecedent 
of malignant disease. CIN is categorized 
primarily according to the extent to which 
squamous cells fail to mature as they 
migrate from the basal zone next to the 
basement membrane to the surface of 
epithelium” (Garrison, Fischer, Karam, 
Leary & Pieters, 2015, p. 3).
The ACS reports (2016), “Pre-cancerous 
changes in a biopsy are called cervical 
intraepithelial neoplasia (CIN). Sometimes 
the term dysplasia is used instead of CIN. 
CIN is graded on a scale of 1 to 3 based on 
how much of the cervical tissue looks 
abnormal when viewed under the 
microscope.”
How are biopsy 
results reported?
The ACS (2016) also explains how the CIN 
results are reported,
• “In CIN1, not much of the tissue looks 
abnormal, and it is considered the 
least serious cervical pre-cancer 
(mild dysplasia).
• In CIN2 more of the tissue looks 
abnormal (moderate dysplasia)
• In CIN3 most of the tissue looks 
abnormal; CIN3 is the most serious 
pre-cancer (severe dysplasia) and 
includes carcinoma in situ).”
Conclusion
Information can be provided to patients 
to prevent and screen for cervical cancer.  
Risk factors can be presented to encourage 
patients to be tested for cervical cancer.  
Education through nursing care is 
important to support patients.  
According to the Centers for Disease 
Control and Prevention (CDC) (2016) 
There are many types of HPV and it usually 
will go away on its own.  If it does not, it 
may cause cervical cancer over time.  
There are other factors that can increase 
your risk of cervical cancer: 
• Smoking. 
• Having HIV (human immunodeficiency 
virus) another virus that can make it hard 
for someone to fight off other infections 
and other immunosuppressive diseases 
• Using birth control pills for over five 
years. 
• Given birth to three or more children. 
(ACS, 2016)
Nursing care includes providing 
information for patients to learn about 
diagnosed diseases.  
“Education is a pivotal factor in 
promoting HPV preventative behaviors. 
Education for the general public about 
HPV, the many cancers predominantly 
caused by HPV infections, and 
characteristics of the vaccine is 
fundamental to increasing vaccination 
rates and dispelling myths about its safety 
and effectiveness. Research analyzing what 
methods are most effective for promoting 
HPV vaccines in women can be utilized to 
encourage receiving the vaccine” (Russell, 
2016).
Implications of 
Nursing Care
Significance of Pathophysiology 
According to the CDC (2015), “Early on, cervical cancer may not cause signs and 
symptoms. Advanced cervical cancer may cause bleeding or discharge from the vagina 
that is not normal for you, such as bleeding after sex. If you have any of these signs, see 
your doctor. They may be caused by something other than cancer, but the only way to 
know is to see your doctor.”
Cervical cancer most commonly takes 10 years to 20 years or more to develop; 
women who are no longer sexually active should still have Pap tests.” (NCCC, 2018)
According to the NCCC (2018), Abnormal bleeding includes the following
“Bleeding between regular menstrual periods
Bleeding after sexual intercourse
Bleeding after douching
Bleeding after a pelvic exam
Bleeding after menopause.”
Other symptoms include, “Pelvic pain not related to your menstrual cycle, heavy or 
unusual discharge that may be watery, thick, and possibly have a foul odor, increased 
urinary frequency, pain during urination” (NCCC, 2018).
It is important to educate patients, even if they are not sexually active anymore 
because HPV can remain dormant for many years (NCCC, 2018).
Signs and Symptoms
Image 1: HPV from common virus to cervical cancer.  As retrieved       
http://www.picstopin.com/195/cervical-cancer-—-uva-
health/https:%7C%7Cuvahealth*com%7CPlone%7Cebsco_images%7C2434*jpg/
Image 2: The Natural History of HPV infection.  As retrieved
http://www.cuhk.edu.hk/sphpc/hpvselfsampling/en/cc-n-hpv.html
Underlying
Pathophysiology
“The introduction of cervical 
screening with cytology has significantly 
reduced morbidity and mortality related 
to cervical cancer in developed nations. 
This is due to the detection of both 
preinvasive changes as well as invasive 
cancer at earlier stages which allows for 
earlier treatment. When abnormal 
cytology and histology is identified, 
patients may be referred to another 
facility for further evaluation and 
management” (Williams et al., 2018, p. 
4).  
By examining the pathophysiology,  
practitioners can assist patients with 
prevention and treatment of HPV and 
cervical cancer. 
“Cervical cancer is the second most 
commonly diagnosed cancer and fourth 
leading cause of cancer death in women 
worldwide” (He et al., 2015, p. 1426).   
Prevention is the key to stopping the 
progression of HPV into cervical cancer.  
Patients and practitioners alike can 
educate themselves to prevent the 
progression of this cancer in women.
According to the NCCC (2018) HPV 
“is the name of a group of viruses that 
infect the skin. There are more than 100 
different types of HPV. Some types of 
genital HPV may cause genital warts, 
while other types of genital HPV are 
linked to abnormal cell changes on the 
cervix (detected through Pap tests) that 
can lead to cervical cancer. However, 
this cancer can almost always be 
prevented through regular screening 
and, if needed, treatment of abnormal 
cell changes.” 
“Epidemiological and molecular 
evidence indicates that high-risk HPV, 
especially HPV type 16 and type 18, 
plays a causative role in cervical cancer” 
(He, Mao, Hua, Lv, Chen, Angeletti, Dong,  
Remmenga,  Rodabaugh,  Zhou, Lambert,  
Yang, Davis, & Wan, 2015, p. 1439).
Caused by a virus?
• According to the NCCC (2018), 
“Cervical cancer is the first 
cancer in women to be identified 
as being caused almost 
exclusively by a virus.”
• HPV is detected in 99.7% of 
patients with cervical cancer. 
(He et al., 2015)
• HPV is linked to other cancers 
including oropharyngeal, oral, 
and some head and neck cancers 
(NCCC, 2018). 
• Regular pap tests can be 
supplemented with additional 
HPV testing to optimize the 
prevention and treatment for 
cervical cancer (NCCC, 2018).
According to the ACS (2016), HPV 
is the main cause of cervical cancer 
and a common virus that is passed 
from one person to another during 
sex. Most sexually active people will 
have HPV at some point, but few 
women Squamous intraepithelial 
lesions (SILs) These abnormalities 
are divided into two categories:
• “In low-grade SIL (LSIL) the cells 
look mildly abnormal” (ACS, 
2016)
• “In high-grade SIL (HSIL) the 
cells look severely abnormal and 
are less likely than the cells in 
LSIL to go away without 
treatment. They are also more 
likely to eventually develop into 
cancer if they are not treated” 
(ACS, 2016)
Additional outside testing can be 
completed to determine the best course of 
action when deciding when and how to treat 
the different stages of CIN and cervical 
cancer.  “There is limited data to support or 
refute whether review of outside pathology 
for diagnostic confirmation is necessary or 
cost effective especially for CIN…This is 
especially important in younger populations 
that desire fertility...treatment for CIN was 
not associated with increased risk of total 
preterm delivery or spontaneous preterm 
delivery but did reveal an increased risk of 
preterm premature rupture of membranes... 
clinically relevant as CIN II is often the 
threshold for treatment and may present as 
a transient process especially in younger 
women. “(Williams, Agner & Stockdale,  
2018,  p.4).
Recognizing the underlying pathophysiology is important for staging cervical cancer. 
“The treatment of cervical cancer is stage-specific. While early stage disease can be cured 
with radiotherapy or surgery, the most effective treatment for locally advanced stage 
patients is concurrent chemotherapy and pelvic irradiation.” (Ordikhani, Arslan, 
Marcelo, Sahin, Grigsby,  Schwarz & Azab,  2016, p. 1)
There are vaccinations that have been used to prevent HPV.  As Camara (2014) 
explores the need for vaccines several facts are presented, “HPV is so common that one 
in every two sexually-active people will contract at least one HPV infection at some point 
during their lifetime.  With over one-hundred identified strains, most infections present 
either minimal or no risk to health in “immunologically-competent” individuals. HPV 
infections are typically “asymptomatic and harmless; most people never know they are 
infected, and most infections typically resolve on their own” (p. 39).  Information and 
statistical findings can be researched and reported to patients in order for them to make 
educated decisions to determine if vaccinations should be used.  
Researching the appropriate treatment for cervical cancer according to the level of 
cell changes that are reflected by the CIN is important.“Pelvic floor disorders are widely 
encountered in women who survive gynecological cancers, and an increasing body of 
evidence shows that these problems are present at baseline, before initiation of cancer 
therapy. Because the primary focus in therapy is cancer eradication, pelvic floor 
disorders are frequently overlooked by both patients and specialists, although they have 
a major impact on patients’ quality of life. Future research should focus on improving 
quality of life in cancer survivors using treatments that cause less damage to the pelvic 
floor compartment” (Bodean, Marcu, Spinu, Socea, Diaconu, Munteanu, Taus, and 
Cirstoiu, 2018).  
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